Injection device
Latest Janssen Pharmaceuticals, Inc. Patents:
- Controlling operation of drug administration devices using surgical hubs
- Multivalent vaccine compositions and uses thereof
- Locking member for an injection device and an injection device trainer
- Methods of producing bioconjugates of O-antigen polysaccharides, compositions thereof, and methods of use thereof
- Compositions comprising aticaprant
Description
The parts shown in broken dashed lines form no part of the claimed design.
Claims
The ornamental design for an injection device, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
D383205 | September 2, 1997 | Pagay |
D429812 | August 22, 2000 | Hjertman et al. |
D574954 | August 12, 2008 | Smith |
8052655 | November 8, 2011 | Moller |
D681808 | May 7, 2013 | Holaschke |
D687544 | August 6, 2013 | Stephan |
D696773 | December 31, 2013 | Schneider |
D696774 | December 31, 2013 | Guarraia |
D696775 | December 31, 2013 | Guarraia |
D697205 | January 7, 2014 | Schneider |
9867940 | January 16, 2018 | Holmqvist |
D814022 | March 27, 2018 | Boyaval |
D844774 | April 2, 2019 | Akcay |
D844777 | April 2, 2019 | Combes |
HD17036853 | February 2006 | JP |
D 1453984 | September 2012 | JP |
D 1454273 | September 2012 | JP |
HJ25013375 | June 2013 | JP |
D 1634750 | May 2019 | JP |
Patent History
Patent number: D888942
Type: Grant
Filed: Apr 10, 2018
Date of Patent: Jun 30, 2020
Assignee: Janssen Pharmaceuticals, Inc. (Titusville, NJ)
Inventors: Michael Cannamela (New York, NY), Rochelle Kleinberg (New York, NY), Peter Krulevitch (Pleasanton, CA)
Primary Examiner: David G Muller
Application Number: 29/643,586
Type: Grant
Filed: Apr 10, 2018
Date of Patent: Jun 30, 2020
Assignee: Janssen Pharmaceuticals, Inc. (Titusville, NJ)
Inventors: Michael Cannamela (New York, NY), Rochelle Kleinberg (New York, NY), Peter Krulevitch (Pleasanton, CA)
Primary Examiner: David G Muller
Application Number: 29/643,586
Classifications